Clinical Trial Update: Cabergoline and Coasting to Prevent OHSS [NA]

View source ↗

Summary

A Cairo University–sponsored clinical trial evaluating cabergoline and coasting to prevent ovarian hyperstimulation syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Hyperstimulation Syndrome

Drugs mentioned

• CABERGOLINE (CABERGOLINE)

Snippet

Sponsor: Cairo University | Conditions: OHSS | NA | Status: COMPLETED